Zortress .5 mg/1

Zortress .5 mg tablets contain everolimus, a medication used to prevent organ rejection after transplants. This oral tablet is manufactured by Novartis Pharmaceuticals Corporation in the USA.

Zortress .5 mg tablets are primarily used to help prevent the body from rejecting a transplanted organ. Everolimus, the active ingredient, works by suppressing the immune system's response. This medication is often prescribed for patients who have undergone kidney transplants. It is important to consult a healthcare provider to determine if Zortress is suitable for your specific condition.

Common effects of Zortress .5 mg tablets may include swelling, high blood pressure, and increased cholesterol levels. Some users might experience headaches, nausea, or diarrhea. These effects can vary from person to person, and not everyone will experience them. If you have concerns about any effects, it is advisable to speak with a healthcare professional.

Zortress .5 mg tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication may interact with other drugs, so it is crucial to inform your healthcare provider about all medications you are taking. Store Zortress in a cool, dry place away from direct sunlight.

Zortress .5 mg tablets may interact with certain medications, including those that affect the immune system or are metabolized by the liver. It is important to avoid grapefruit and grapefruit juice, as they can increase the levels of everolimus in the blood. Always consult your healthcare provider before starting or stopping any medication while taking Zortress.